Cofoe Medical Technology Co.,Ltd. (ASX: 301087) has disclosed a plan to repurchase a portion of its A-shares through centralized competitive bidding on the exchange.

The repurchased shares are intended to be cancelled in full, leading to a reduction in the company's registered capital.

The total amount of funds allocated for this buyback program is set at no less than 1 billion yuan and no more than 2 billion yuan.

The maximum repurchase price has been established at 69.66 yuan per share.